With Circular E.2023/2023, the Independent Authority of Public Revenue (“IAPR”) has eventually shed light on the income tax treatment of VAT corresponding to rebates refunded to pharmaceutical companies, in cases where such VAT had been deducted for income tax purposes in previous fiscal years.
Source PwC
Latest Posts in "Greece"
- Greece Introduces Mandatory B2B E-Invoicing Starting February 2026
- Pierrakakis at ECOFIN: Innovation and Digitalization as Europe’s Competitiveness Drivers
- Greek IAPR Announces Mandatory B2B E-Invoicing Implementation Timeline and Incentives
- Greece to Implement Mandatory B2B E-Invoicing from February 2026 for Non-EU Exports
- Greece Announces Phased Deadlines for Mandatory B2B E-Invoicing Implementation Starting 2026
